Alcon’s war on waste
Alcon is cutting back on packaging material manufacturing and reducing waste going to NZ landfills.
Susanne Bradley4 min read
Ophthalmology News
Concern over repeal of Therapeutic Products Act
The Therapeutics Products Act (TPA) 2023 has been repealed, despite being hailed by now-former health minister Dr Ayesha Verrall as the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years.
Staff reporters2 min read
Southern Vision Bus canned
BLVNZ is pulling the plug on its joint venture with Rotary to fund and operate a Southern Vision Bus.
Susanne Bradley2 min read
CDR-Life’s GA therapy advances
CDR-Life is recruiting for phase 2 clinical trials of its novel antibody fragment-based therapy for geographic atrophy (GA), following favourable phase 1 safety results.
Staff reporters1 min read
Novel therapy repairs ‘irreversible’ corneal damage
A groundbreaking, experimental stem cell treatment for blinding cornea injuries resulted in a 92% success rate at 18 months.
Staff reporters2 min read
AI accelerator for drug research unveiled
An Australian research team has developed a large language model (LLM) designed to speed up scientific discovery in molecular property prediction. Lead co-author, PhD candidate Yizhen Zheng, from Mo
Staff reporters1 min read
Middle-aged retinas reveal Alzheimer’s risk
An international team including New Zealand researchers found measures of retinal health captured the risk of Alzheimer's disease and related dementias (ADRD) across several domains of known risk fact
Staff reporters1 min read
Submission sought on MoH review
The Ministry of Health (MoH) is reviewing the regulation of the New Zealand health workforce and is asking for submissions.
Staff reporters1 min read
Early genetic intervention spares kids’ vision
A Moorfields-led team improved the visual acuity (VA) in children with retinal dystrophy caused by a genetic deficiency of AIPL1, using a viral vector to deliver healthy copies of the gene to their re
Staff reporters2 min read
First patient dosed in Stargardt gene therapy trial
SpliceBio, a clinical-stage genetic medicine company pioneering protein splicing, has dosed the first patient in the phase 1/2 ASTRA study of SB-007, a dual adeno-associated viral (AAV) vector for the
Staff reporters1 min read
Getting theatrical about cataracts: factors affecting surgical capacity
With waiting lists growing, Drew Jones delves into the factors affecting cataract surgery efficiency
Drew Jones8 min read
AMD stem-cell therapy bolstered
Luxa Biotechnology announced trial results showing substantial improvements in best corrected visual acuity (BCVA) for patients receiving its novel adult retinal pigment epithelial stem cell therapy (
Staff reporters2 min read